Styrenix Performance Materials (506222) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
29 Oct, 2026Executive summary
Q2 FY27 standalone revenue and PAT rose YoY, while consolidated EBITDA and PAT declined; H1 earnings increased strongly on both bases.
Phase I expansion is on schedule for FY27 commissioning; Thailand operations face competitive pressure and are pursuing cost and utilization improvements.
Financial highlights
Standalone Q2 revenue from operations was ₹779.70 crore, up 26.7% YoY; EBITDA was ₹84.5 crore, up 3.3%, and PAT was ₹51.2 crore, up 0.8%.
Consolidated Q2 revenue was ₹993.51 crore, up YoY; PBDIT was ₹75.60 crore versus ₹88.43 crore, and PAT was ₹23.17 crore versus ₹44.72 crore.
Standalone H1 revenue was ₹1,547.74 crore, EBITDA ₹285.88 crore and PAT ₹188.52 crore, up 15.8%, 70.3% and 78.4% YoY, respectively.
Consolidated H1 revenue was ₹2,004.37 crore, PBDIT ₹299.18 crore and PAT ₹161.46 crore, up 15.0%, 58.9% and 67.0% YoY, respectively.
Standalone Q2 total income was ₹781 crore, up 26.5% YoY; Q2 sales volume was 43.4 KT.
Outlook and guidance
India ABS brownfield Phase I expansion of 50 KT remains on schedule, with commissioning expected in H2 FY27; commissioning timing across the Phase I plants may vary within a quarter.
Management expects a large part of new capacity to be utilized in the next FY and considers full utilization achievable; no specific volume guidance was given.
Phase II ABS expansion remains on its original timeline, with work expected to begin after Phase I comes online; no completion date was specified.
Thailand utilization is targeted to improve progressively over two years through market development, customer engagement, cost realignment and sharper commercial focus.
ABS H2 volumes are expected to track Q2; HIPS should remain near full utilization annually, while GPPS recovery depends on demand and procurement conditions.
Latest events from Styrenix Performance Materials
- Stable EBITDA margin and strong dividend despite lower revenue; major capacity expansion underway.506222
Q4 23/24 - Q1 FY27 profit and margins surged as expansion plans advanced despite global volatility.506222
Q1 26/27 - Profitability rose on margin gains and global expansion, with a one-time Labour Code cost.506222
Q4 25/26 - Revenue grew but margins fell in Q3 FY 2026 amid Thailand losses and ongoing expansion.506222
Q3 25/26 - Q1 FY25 profit after tax surged 88.6% YoY on strong sales, margin gains, and high capacity use.506222
Q1 24/25 - Q3 FY25 saw strong revenue and profit growth, led by Thailand acquisition and expansions.506222
Q3 24/25 - Revenue and profit surged on robust demand, expansion, and the Thailand acquisition.506222
Q4 24/25 - Q1 FY26 saw record sales, specialty growth, and Thailand integration driving future prospects.506222
Q1 25/26 - Sales volumes up YoY, profits and margins down; APAC expansion and demand support outlook.506222
Q2 25/26